Cargando…

Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2

The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) mediates viral entry into target cells. Cleavage and activation of SARS S by a host cell protease is essential for infectious viral entry and the responsible enzymes are potential targets for antiviral intervention. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reinke, Lennart Michel, Spiegel, Martin, Plegge, Teresa, Hartleib, Anika, Nehlmeier, Inga, Gierer, Stefanie, Hoffmann, Markus, Hofmann-Winkler, Heike, Winkler, Michael, Pöhlmann, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479546/ https://www.ncbi.nlm.nih.gov/pubmed/28636671 http://dx.doi.org/10.1371/journal.pone.0179177

Ejemplares similares

Priming Time: How Cellular Proteases Arm Coronavirus Spike Proteins
por: Hoffmann, Markus, et al.
Publicado: (2018)

Evidence that Processing of the Severe Fever with Thrombocytopenia Syndrome Virus Gn/Gc Polyprotein Is Critical for Viral Infectivity and Requires an Internal Gc Signal Peptide
por: Plegge, Teresa, et al.
Publicado: (2016)

Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins
por: Plegge, Teresa, et al.
Publicado: (2019)

H2 influenza A virus is not pathogenic in Tmprss2 knock-out mice
por: Lambertz, Ruth Lydia Olga, et al.
Publicado: (2020)

TMPRSS2 Isoform 1 Activates Respiratory Viruses and Is Expressed in Viral Target Cells
por: Zmora, Pawel, et al.
Publicado: (2015)

TMPRSS11A activates the influenza A virus hemagglutinin and the MERS coronavirus spike protein and is insensitive against blockade by HAI-1
por: Zmora, Pawel, et al.
Publicado: (2018)

Non-human primate orthologues of TMPRSS2 cleave and activate the influenza virus hemagglutinin
por: Zmora, Pawel, et al.
Publicado: (2017)

Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts
por: Bertram, Stephanie, et al.
Publicado: (2012)

Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
por: Hoffmann, Markus, et al.
Publicado: (2020)

Virion Background and Efficiency of Virion Incorporation Determine Susceptibility of Simian Immunodeficiency Virus Env-Driven Viral Entry to Inhibition by IFITM Proteins
por: Wrensch, Florian, et al.
Publicado: (2017)

Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
por: Hoffmann, Markus, et al.
Publicado: (2021)

The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cells
por: Brinkmann, Constantin, et al.
Publicado: (2017)

The Role of Phlebovirus Glycoproteins in Viral Entry, Assembly and Release
por: Spiegel, Martin, et al.
Publicado: (2016)

Role of rhesus macaque IFITM3(2) in simian immunodeficiency virus infection of macaques
por: Winkler, Michael, et al.
Publicado: (2019)

TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection
por: Metzdorf, Kristin, et al.
Publicado: (2023)

Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease
por: Stevaert, Annelies, et al.
Publicado: (2022)

Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research
por: Simmons, Graham, et al.
Publicado: (2013)

Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein
por: Kleine-Weber, Hannah, et al.
Publicado: (2018)

Native and activated antithrombin inhibits TMPRSS2 activity and SARS‐CoV‐2 infection
por: Wettstein, Lukas, et al.
Publicado: (2022)

SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
por: Hoffmann, Markus, et al.
Publicado: (2021)

The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency
por: Arora, Prerna, et al.
Publicado: (2021)

Identification of TMPRSS6 cleavage sites of hemojuvelin
por: Rausa, Marco, et al.
Publicado: (2015)

Host Cell Factors in Filovirus Entry: Novel Players, New Insights
por: Hofmann-Winkler, Heike, et al.
Publicado: (2012)

No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2
por: Arora, Prerna, et al.
Publicado: (2022)

Structure-based drug repositioning over the human TMPRSS2 protease domain: search for chemical probes able to repress SARS-CoV-2 Spike protein cleavages
por: Singh, Natesh, et al.
Publicado: (2020)

Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein
por: Budhadev, Darshita, et al.
Publicado: (2023)

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
por: Hoffmann, Markus, et al.
Publicado: (2020)

Comparative Analysis of Host Cell Entry of Ebola Virus From Sierra Leone, 2014, and Zaire, 1976
por: Hofmann-Winkler, Heike, et al.
Publicado: (2015)

IFITM Proteins Inhibit Entry Driven by the MERS-Coronavirus Spike Protein: Evidence for Cholesterol-Independent Mechanisms
por: Wrensch, Florian, et al.
Publicado: (2014)

TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein
por: Kishimoto, Mai, et al.
Publicado: (2021)

Different host cell proteases activate the SARS-coronavirus spike-protein for cell–cell and virus–cell fusion
por: Simmons, Graham, et al.
Publicado: (2011)

LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus
por: Gramberg, Thomas, et al.
Publicado: (2005)

Improving Soluble Expression of SARS-CoV-2 Spike Priming Protease TMPRSS2 with an Artificial Fusing Protein
por: Ye, Xiao, et al.
Publicado: (2023)

Spike residue 403 affects binding of coronavirus spikes to human ACE2
por: Zech, Fabian, et al.
Publicado: (2021)

Lack of MERS Coronavirus Neutralizing Antibodies in Humans, Eastern Province, Saudi Arabia
por: Gierer, Stefanie, et al.
Publicado: (2013)

Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression
por: Gnirß, Kerstin, et al.
Publicado: (2012)

Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity
por: Du, Lanying, et al.
Publicado: (2007)

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
por: Hoffmann, Markus, et al.
Publicado: (2020)

Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance
por: Arora, Prerna, et al.
Publicado: (2021)

Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2
por: Arora, Prerna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_grep6ib4b4fn640vr5gi2j7ha1